Clinical Study
Ulcerative Granular Cell Tumor: A Clinicopathological and Immunohistochemical Study
Table 1
The clinicopathological and immunohistochemical features of ulcerative GCT.
| Clinical data |
| (i) Age (years) | | Range | 17–42 y. | Mean ± SD | 31.5 ± 7.42 |
| (ii) Sex | | Males/females | 11/3 | Ratio | 3.6 : 1 |
| (iii) Duration of the lesion (months) | | Range | 23–51 m. | Mean ± SD | 37.2 ± 8.32 |
| (iv) Time of 2ry ulceration (months) | | Range | 19–41 m. | Mean ± SD | 31.5 ± 6.71 |
| (v) Location | | Extremities | 12 (5 arm, 2 forearm, 3 foot, 1 leg and 1 thigh) | Anogenital | 1 scrotum and 1 perineum |
| (vi) Size of the base (cm) | | Range | 3.8 × 3.5–5.2 × 5.1 | Average | 4.1 × 3.9 |
| Histological features |
| (I) Epidermal changes | Acanthosis: 11 | Pseudoepitheliomatous hyperplasia: 3 |
| (ii) Cellular infiltrate | Dermal: 12 | Dermal and subcutaneous: 2 |
| (iii) Appendageal infiltrate | Muscle infiltrate: 14 |
| (iv) PAS stain | Strong positive: 10 | Weak positive: 4 |
| Immunohistochemical features |
| (i) Positive staining | S100 and NSE: 14 (all strong) | Vimentin: 7 (6 strong–1 weak) | CD68 : 5 (all weak) |
| (ii) Negative staining | Desmin, HMB45, EMA and CK |
|
|